Evidence map›Paper›PMID 34592058›Full record

ReviewJournal of thrombosis and haemostasis : JTH2021

Clinical use of thrombin generation assays.

Nikolaus B Binder, François Depasse, Julia Mueller, Thomas Wissel, Stephan Schwers, Matthias Germer, Björn Hermes, Peter L Turecek

Open access · hybridAbstract readReview
In one paragraph

Review in Journal of thrombosis and haemostasis : JTH, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
10.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 96 citations in OpenAlex.

  1. Observational
  2. Article
  3. Laboratory Challenges in the Era of Novel Haemophilia Therapies.Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Resistance to age-related hypercoagulability: insights from the naked mole rat.Research and practice in thrombosis and haemostasis · 2026
    Article
  8. Article
  9. Article
  10. Key markers and detection methods for evaluating platelet dysfunction in mechanical circulatory support devices.Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs · 2025
    Review
  11. Article
  12. Normalization in hemophilia: conceptual foundations and clinical implications.Research and practice in thrombosis and haemostasis · 2025
    Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Observational
  19. Article
  20. Dual direct oral anticoagulant therapy in challenging thrombosis: a case series.Research and practice in thrombosis and haemostasis · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 4 countries.

Nikolaus B BinderTechnoclone Herstellung von Diagnostika und Arzneimitteln GmbH.
François DepasseDiagnostica Stago.
Julia MuellerSiemens Healthcare Diagnostics Products GmbH.
Thomas WisselSiemens Healthcare Diagnostics Products GmbH.
Stephan SchwersBayer AG.
Matthias GermerBiotest AG.
Björn HermesDIN e.V. - DIN Standards Committee Medicine (NAMed).
Peter L TurecekBaxalta Innovations GmbH, part of the Takeda group of companies.ORCID 0000-0002-6161-1556
Deutsches Institut für Normung · DESiemens Healthineers (Germany) · DEBiotest (Germany) · DEMundipharma (United Kingdom) · GBStago (France) · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Determining patient's coagulation profile, i.e. detecting a bleeding tendency or the opposite, a thrombotic risk, is crucial for clinicians in many situations. Routine coagulation assays and even more specialized tests may not allow a relevant characterization of the hemostatic balance. In contrast, thrombin generation assay (TGA) is a global assay allowing the dynamic continuous and simultaneous recording of the combined effects of both thrombin generation and thrombin inactivation. TGA thus reflects the result of procoagulant and anticoagulant activities in blood and plasma. Because of this unique feature, TGA has been widely used in a wide array of settings from both research, clinical and pharmaceutical perspectives. This includes diagnosis, prognosis, prophylaxis, and treatment of inherited and acquired bleeding and thrombotic disorders. In addition, TGA has been shown to provide relevant information for the diagnosis of coagulopathies induced by infectious diseases, comprising also disturbance of the coagulation system in COVID-19, or for the assessment of early recurrence in breast cancer. This review article aims to document most clinical applications of TGA.

Indexed as

Blood Coagulation TestsThrombinBlood Coagulation DisordersCOVID-19HumansNeoplasm Recurrence, LocalSARS-CoV-2Thrombincoagulation assayhemostasisTGAthrombin generation assaythrombosis

Identifiers

PMID34592058
PMCPMC9292855
OpenAlexW3202177894

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.